Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transforming growth factor beta-1-induced transcript 1 protein (TGFB1I1) is a multi-functional adapter and coactivator protein, encoded by the TGFB1I1 gene in humans. Its expression is induced by transforming growth factor beta-1 (TGFB1) and hydrogen peroxide. It is predominantly localized at the focal adhesion complexes, but also shuttles between the cytoplasm and nucleus. TGFB1I1 functions as a scaffold at focal adhesions, coordinates protein-protein interactions, and acts as a nuclear coactivator for several hormone receptors, including androgen and glucocorticoid receptors. These activities allow TGFB1I1 to regulate signal transduction, cellular proliferation, migration, differentiation, and senescence. Its involvement in cancer (including prostate cancer) and its role as an androgen receptor coactivator highlight its therapeutic relevance[1][2][8].
No specific mechanism is defined for drugs binding directly to TGFB1I1, but drugs modulating androgen receptor activity could alter TGFB1I1’s coactivator function, impacting AR signaling and downstream transcriptional outcomes[2].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transforming growth factor beta-1-induced transcript 1 protein (TGFB1I1).